The study aims at demonstrating the efficiency of
phytotherapy in regulation of
prolactin levels in patients diagnosed with pituitary
macroprolactinoma. The study made use of workup outcomes submitted by treating healthcare facilities where the patients were first diagnosed with
macroprolactinomas based on diagnostic imaging (MRI and/or CT), laboratory workup, and
hormone status estimation. The data in reference served as the baseline for a comparative follow-up of phytotherapeutic efficiency in terms of comparison of medical data obtained prior to
phytotherapy and those submitted following herbal remedy use. The study displays the results of a five-year follow-up of
macroprolactinoma patients undergoing
phytotherapy. In well-responding patients, the benefit of
phytotherapy in terms of
prolactin level putdown can be seen 3-5 months following the
phytotherapy commencement. A special attention should be paid to the favourable results obtained with patients who chose to resort to
phytotherapy only. The primary outcome measure used to monitor the efficiency of the administered
phytotherapy was
prolactin level determined prior to, during the course of, and following
phytotherapy. Implementation of
phytotherapy to the effect of
prolactin level regulation in patients diagnosed with
macroprolactinoma, represents a completely novel therapeutic approach. The majority of the diseased resorted to
phytotherapy once they were left out of any other therapeutic option offered by their treating healthcare facilities. This fact gives a substantial rise to the significance of the results presented herein and justifies the role of
phytotherapy in
macroprolactinoma-induced
hyperprolactinaemia treatment.